Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research - United States
doi 10.1158/0008-5472.can-18-1281
Full Text
Open PDFAbstract
Available in full text
Date
February 4, 2019
Authors
Publisher
American Association for Cancer Research (AACR)